<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Qin XP</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study determined the predictive value of CRMP4 promoter methylation in prostate tissues collected by core needle biopsies for a postoperative upgrade of Gleason Score (GS) to ≥8 in patients with low-risk PCa.&lt;h4>Method&lt;/h4>A retrospective analysis of the clinical data was conducted from 631 patients diagnosed with low-risk PCa by core needle biopsy at multiple centers and then underwent Radical Prostatectomy (RP) from 2014-2019. Specimens were collected by core needle biopsy to detect CRMP4 promoter methylation. The pathologic factors correlated with the postoperative GS upgrade to ≥8 were analyzed by logistic regression. The cut-off value for CRMP4 promoter methylation in the prostate tissues collected by core needle biopsy was estimated from the ROC curve in patie</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>840950</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8960729</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer.</pubmed_title><pmcid>PMC8960729</pmcid><pubmed_authors>Zhuo YM</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Liu JM</pubmed_authors><pubmed_authors>Yang CH</pubmed_authors><pubmed_authors>Liu WP</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Li YH</pubmed_authors><pubmed_authors>Qin XP</pubmed_authors><pubmed_authors>Xu YS</pubmed_authors><pubmed_authors>Qu LJ</pubmed_authors><pubmed_authors>Qian HJ</pubmed_authors><pubmed_authors>Yi XL</pubmed_authors><pubmed_authors>Lu QJ</pubmed_authors><pubmed_authors>Chen JF</pubmed_authors><pubmed_authors>Lai CY</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Ren SC</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors><pubmed_authors>Pan YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer.</name><description>&lt;h4>Background&lt;/h4>This study determined the predictive value of CRMP4 promoter methylation in prostate tissues collected by core needle biopsies for a postoperative upgrade of Gleason Score (GS) to ≥8 in patients with low-risk PCa.&lt;h4>Method&lt;/h4>A retrospective analysis of the clinical data was conducted from 631 patients diagnosed with low-risk PCa by core needle biopsy at multiple centers and then underwent Radical Prostatectomy (RP) from 2014-2019. Specimens were collected by core needle biopsy to detect CRMP4 promoter methylation. The pathologic factors correlated with the postoperative GS upgrade to ≥8 were analyzed by logistic regression. The cut-off value for CRMP4 promoter methylation in the prostate tissues collected by core needle biopsy was estimated from the ROC curve in patie</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T12:54:36.695Z</modification><creation>2025-04-19T12:54:36.695Z</creation></dates><accession>S-EPMC8960729</accession><cross_references><pubmed>35359369</pubmed><doi>10.3389/fonc.2022.840950</doi></cross_references></HashMap>